EKSO Share Price Performance
US$4.79
-6.59 (-57.93%)
49.6% undervalued intrinsic discount
US$9.50
Fair Value
Price US$4.79
AnalystHighTarget US$9.50
AnalystConsensusTarget US$6.75
AnalystLowTarget US$4.00
Fair ValueUS$9.50
Share Pricen/a
Ekso Bionics Holdings, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
EKSO Community Narratives
AN
Fair Value US$9.5 49.6% undervalued intrinsic discount
Rising Healthcare Spending And Aging Populations Will Expand Rehab Robotics
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value US$6.75 29.0% undervalued intrinsic discount
Advanced Exoskeleton Devices Will Broaden Rehabilitation Market Access
1users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
Fair Value US$4 19.8% overvalued intrinsic discount
Enterprise Order Delays Will Weaken Performance But Spark Opportunity
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Rising Healthcare Spending And Aging Populations Will Expand Rehab Robotics
Key Takeaways Accelerated personal exoskeleton adoption, strategic partnerships, and ecosystem initiatives position the company for rapid market penetration and substantial revenue growth beyond conservative forecasts. Integration of proprietary AI technology and expansion into multiple high-demand segments create strong competitive advantages, premium pricing potential, and long-term margin expansion.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$9.5
49.6% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
22.6% p.a.
Profit Margin
12.32%
Future PE
10.94x
Share price in 2028
US$6.35
Advanced Exoskeleton Devices Will Broaden Rehabilitation Market Access
Key Takeaways Accelerated adoption and revenue growth are expected from improved reimbursement, regulatory changes, and expanded distribution partnerships. Ongoing AI-driven innovation and recovery of delayed sales position Ekso Bionics for enhanced margins and future earnings stability.Read more
1users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
US$6.75
29.0% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
22.4% p.a.
Profit Margin
12.49%
Future PE
7.74x
Share price in 2028
US$4.52
Enterprise Order Delays Will Weaken Performance But Spark Opportunity
Key Takeaways Regulatory changes and demographic trends support long-term demand, but unpredictable reimbursement and healthcare funding limit near-term revenue growth and cash flow stability. Product and partnership expansion offers diversification, though dependence on delayed enterprise sales and high R&D costs could defer profitability.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$4
19.8% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
22.45% p.a.
Profit Margin
12.49%
Future PE
4.58x
Share price in 2028
US$2.68
Snowflake Analysis
Ekso Bionics Holdings, Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -3.14
- 53.48%
- -72.28%
- 44.0%
About EKSO
- Founded
- 2005
- Employees
- 64
- CEO
- WebsiteView website
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
